Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TD-8954 vs Metoclopramide in Enteral Feeding Intolerance
NCT01953081Phase 2Completed
- Sponsor
- Takeda
- Start
- Jan 2014
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of felcisetrag in enteral feeding intolerance (EFI), sponsored by Takeda. Started Jan 2014; status: completed.
02
Drugs
felcisetrag
03
Conditions
enteral feeding intolerance (EFI)
Beyond the preview
Go deeper on NCT01953081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01953081.